Sofwave Medical Ltd. (IL:SOFW)
TASE:SOFW
Want to see IL:SOFW full AI Analyst Report?
SOFW Stock Chart & Stats
2800.00
-0.53(-3.47%)
At close: 4:00 PM EST
2800.00
-0.53(-3.47%)
Day’s Range― - ―
52-Week Range1,935.00 - 4,869.00
Previous CloseN/A
Volume25.73K
Average Volume (3M)26.78K
Market Cap
₪1.50B
Enterprise Value459.88M
Total Cash (Recent Filing)₪35.49M
Total Debt (Recent Filing)₪1.44M
Price to Earnings (P/E)63.3
Beta0.62
Next Earnings
Aug 11, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.23
Shares Outstanding36,295,260
10 Day Avg. Volume28,238
30 Day Avg. Volume26,779
Financial Highlights & Ratios
PEG Ratio-0.22
Price to Book (P/B)9.34
Price to Sales (P/S)3.22
P/FCF Ratio21.06
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
High Gross Margins And Operating ProfitabilitySustained high gross margins (~75%) and positive operating/net margins create structural profitability that supports reinvestment in R&D, sales and service. Margins cushion the business through demand variability, enable scalable unit economics for consumables and improve long-term free cash flow resilience.
Strong Operating Cash Flow And Free Cash Flow GenerationA clear turnaround to positive operating cash flow and FCF provides durable internal funding for capital equipment, service infrastructure and working-capital needs. Near-parity of FCF to net income signals earnings quality and reduces reliance on external financing over the medium term.
Conservative Balance Sheet With Very Low Leverage And Strong ROEMinimal debt and a conservative capital structure give strategic flexibility to invest in growth, absorb cyclical swings, or pursue M&A. A high TTM ROE (~26%) indicates efficient capital deployment, improving shareholder returns while keeping financial risk low over the next several quarters.
Bears Say
Uneven Revenue Growth And Normalization RiskVolatile year-to-year revenue growth undermines predictability for capacity planning and recurring revenue expansion. A sharp slowdown in 2025 followed by partial re-acceleration means sustained top-line momentum is not yet proven, increasing execution risk for multi-quarter targets.
Revenue Dependence On Installed-base Adoption And ConsumablesBusiness economics rely heavily on growing and engaging the installed base so consumable and service attach rates scale. If customer adoption, procedure volumes, or replacement cycles slow, the recurring revenue engine weakens, making growth and margin leverage harder to sustain long term.
Cash Conversion Not Consistently Covering Profit (working-capital Drag)Although absolute cash flow is healthy, conversion below 1 implies timing or working-capital inefficiencies that can strain liquidity during ramp periods. This reduces free cash available for reinvestment and may necessitate short-term financing if growth accelerates unevenly.
Sofwave News
SOFW FAQ
What was Sofwave Medical Ltd.’s price range in the past 12 months?
Sofwave Medical Ltd. lowest stock price was 1935.00 and its highest was 4869.00 in the past 12 months.
What is Sofwave Medical Ltd.’s market cap?
Sofwave Medical Ltd.’s market cap is ₪1.50B.
When is Sofwave Medical Ltd.’s upcoming earnings report date?
Sofwave Medical Ltd.’s upcoming earnings report date is Aug 11, 2026 which is in 50 days.
How were Sofwave Medical Ltd.’s earnings last quarter?
Sofwave Medical Ltd. released its earnings results on May 05, 2026. The company reported 10.9 earnings per share for the quarter, beating the consensus estimate of N/A by 10.9.
Is Sofwave Medical Ltd. overvalued?
According to Wall Street analysts Sofwave Medical Ltd.’s price is currently Overvalued.
Does Sofwave Medical Ltd. pay dividends?
Sofwave Medical Ltd. does not currently pay dividends.
What is Sofwave Medical Ltd.’s EPS estimate?
Sofwave Medical Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Sofwave Medical Ltd. have?
Sofwave Medical Ltd. has 36,295,260 shares outstanding.
What happened to Sofwave Medical Ltd.’s price movement after its last earnings report?
Sofwave Medical Ltd. reported an EPS of 10.9 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 7.99%.
Which hedge fund is a major shareholder of Sofwave Medical Ltd.?
Currently, no hedge funds are holding shares in IL:SOFW
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Sofwave Medical Ltd.
Founded in 2015, Sofwave Medical Ltd. is an Israeli company dedicated to developing cutting-edge ultrasound technology. This technology is employed for the non-invasive treatment of fine lines and wrinkles, with the company's reach extending to physicians both in Israel and internationally. Headquartered in Yokne'am Illit, Israel, they provide advanced aesthetic medical devices for skin care.